Columbia, Missouri 65202

  • Lumbar Disc Herniation

Purpose:

The purpose of this study is to determine a grading system for inflammation in lumbar disc herniation and which groups, if any, benefit most from the administration of an intra-operative epidural steroid.


Study summary:

Intraoperative epidural administration of steroids following discectomy for herniated lumbar disc has been the topic of multiple studies in the literature. The results have been mixed, with the majority of the studies finding some benefit, but outcomes have varied drastically amongst the many studies. The aim of this study is to develop a grading scale for intraoperative assessment of nerve root inflammation to determine if this subjective assessment is an adequate indicator for response to epidural steroids following discectomy. Patients will be allocated randomly preoperatively to the intervention group versus control group. Pictures of the spinal cord and associated nerve root will be captured intraoperatively. These pictures will be scrutinized postoperatively and an inflammation grade will be assigned. The investigators will then identify if nerve roots with a higher-grade of inflammation respond differently to epidural steroid administration when compared to lesser-grades of inflammation. This will be measured with the a variety of outcome measures.


Criteria:

Inclusion Criteria: - Presenting to the University of Missouri hospital system - including the University of Missouri Hospital and Missouri Orthopaedic Institute - with a clinical assessment indicative of a lumbar disc herniation - Failed conservative treatment - rest, anti-inflammatory medications, physical therapy - Radiculopathy present - positive tension signs or sensory/motor neurologic deficits present - Recent MRI confirming single-level lumbar disc herniation corresponding to clinical evaluation Exclusion Criteria: - Concomitant spinal stenosis, segmental instability, or spondylolisthesis - Previous surgery at the affected level or recurrent herniation - Underlying disease that may affect response to steroids - immunocompromise, use of chronic steroids or immunosuppression - Pregnancy - qualitative human chorionic gonadotropin (hCG) testing will be performed prior to enrollment - Diagnosis of or symptoms concerning for cauda equina syndrome


NCT ID:

NCT04182997


Primary Contact:

Principal Investigator
Don Kim Moore, MD
Missouri Orthopaedic Institute

Stacee Clawson, BSN, RN
Phone: (573) 884-9017
Email: clawsons@health.missouri.edu


Backup Contact:

N/A


Location Contact:

Columbia, Missouri 65202
United States

Casey A Fogarty, BS
Phone: 573-882-2328
Email: fogartyca@health.missouri.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: August 03, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.